172 related articles for article (PubMed ID: 38833322)
1. Themis: advancing precision oncology through comprehensive molecular subtyping and optimization.
Xi Y; Zheng K; Deng F; Liu Y; Sun H; Zheng Y; Tong HHY; Ji Y; Zhang Y; Chen W; Zhang Y; Zou X; Hao J
Brief Bioinform; 2024 May; 25(4):. PubMed ID: 38833322
[TBL] [Abstract][Full Text] [Related]
2. Precision Medicine and Targeted Therapies in Breast Cancer.
Greenwalt I; Zaza N; Das S; Li BD
Surg Oncol Clin N Am; 2020 Jan; 29(1):51-62. PubMed ID: 31757313
[TBL] [Abstract][Full Text] [Related]
3. Precision medicine in breast cancer.
Naito Y; Urasaki T
Chin Clin Oncol; 2018 Jun; 7(3):29. PubMed ID: 30056731
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and comparison of multi-omics data integration methods for cancer subtyping.
Duan R; Gao L; Gao Y; Hu Y; Xu H; Huang M; Song K; Wang H; Dong Y; Jiang C; Zhang C; Jia S
PLoS Comput Biol; 2021 Aug; 17(8):e1009224. PubMed ID: 34383739
[TBL] [Abstract][Full Text] [Related]
5. Artificial intelligence, molecular subtyping, biomarkers, and precision oncology.
Shen JP
Emerg Top Life Sci; 2021 Dec; 5(6):747-756. PubMed ID: 34881776
[TBL] [Abstract][Full Text] [Related]
6. DO CANCER CLINICAL TRIAL POPULATIONS TRULY REPRESENT CANCER PATIENTS? A COMPARISON OF OPEN CLINICAL TRIALS TO THE CANCER GENOME ATLAS.
Geifman N; Butte AJ
Pac Symp Biocomput; 2016; 21():309-20. PubMed ID: 26776196
[TBL] [Abstract][Full Text] [Related]
7. Subtype-WGME enables whole-genome-wide multi-omics cancer subtyping.
Yang H; Zhao L; Li D; An C; Fang X; Chen Y; Liu J; Xiao T; Wang Z
Cell Rep Methods; 2024 Jun; 4(6):100781. PubMed ID: 38761803
[TBL] [Abstract][Full Text] [Related]
8. [Precision oncology and molecular tumor boards].
Mack E; Horak P; Fröhling S; Neubauer A
Inn Med (Heidelb); 2024 May; 65(5):462-471. PubMed ID: 38652307
[TBL] [Abstract][Full Text] [Related]
9. Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.
Passaro A; Al Bakir M; Hamilton EG; Diehn M; André F; Roy-Chowdhuri S; Mountzios G; Wistuba II; Swanton C; Peters S
Cell; 2024 Mar; 187(7):1617-1635. PubMed ID: 38552610
[TBL] [Abstract][Full Text] [Related]
10. Harnessing the potential of reverse-phase protein array technology: Advancing precision oncology strategies.
Masuda M; Nakagawa R; Kondo T
Cancer Sci; 2024 May; 115(5):1378-1387. PubMed ID: 38409909
[TBL] [Abstract][Full Text] [Related]
11. Genomic and transcriptional heterogeneity-based precision in personalized treatment for breast cancer.
Antoniou P; Ziogas DE; Vlachioti A; Lykoudis EG; Mitsis M; Roukos DH
Per Med; 2019 Sep; 16(5):361-364. PubMed ID: 31507233
[No Abstract] [Full Text] [Related]
12. Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinations.
Letai A; Bhola P; Welm AL
Cancer Cell; 2022 Jan; 40(1):26-35. PubMed ID: 34951956
[TBL] [Abstract][Full Text] [Related]
13. Generalizable transcriptome-based tumor malignant level evaluation and molecular subtyping towards precision oncology.
Hu D; Zhang Z; Liu X; Wu Y; An Y; Wang W; Yang M; Pan Y; Qiao K; Du C; Zhao Y; Li Y; Bao J; Qin T; Pan Y; Xia Z; Zhao X; Sun K
J Transl Med; 2024 May; 22(1):512. PubMed ID: 38807223
[TBL] [Abstract][Full Text] [Related]
14. Clonotyping for precision oncology.
Dang HX; Maher CA
Drug Discov Today; 2015 Dec; 20(12):1464-9. PubMed ID: 26494143
[TBL] [Abstract][Full Text] [Related]
15. Clinical target sequencing for precision medicine of breast cancer.
Tsuchida J; Rothman J; McDonald KA; Nagahashi M; Takabe K; Wakai T
Int J Clin Oncol; 2019 Feb; 24(2):131-140. PubMed ID: 30604156
[TBL] [Abstract][Full Text] [Related]
16. Precision Oncology Decision Support: Current Approaches and Strategies for the Future.
Kurnit KC; Dumbrava EEI; Litzenburger B; Khotskaya YB; Johnson AM; Yap TA; Rodon J; Zeng J; Shufean MA; Bailey AM; Sánchez NS; Holla V; Mendelsohn J; Shaw KM; Bernstam EV; Mills GB; Meric-Bernstam F
Clin Cancer Res; 2018 Jun; 24(12):2719-2731. PubMed ID: 29420224
[TBL] [Abstract][Full Text] [Related]
17. Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
Schmidt KT; Chau CH; Price DK; Figg WD
J Clin Pharmacol; 2016 Dec; 56(12):1484-1499. PubMed ID: 27197880
[TBL] [Abstract][Full Text] [Related]
18. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
19. MCNF: A Novel Method for Cancer Subtyping by Integrating Multi-Omics and Clinical Data.
Zhao L; Yan H
IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(5):1682-1690. PubMed ID: 30990192
[TBL] [Abstract][Full Text] [Related]
20. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
Blumenthal GM; Mansfield E; Pazdur R
JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
[No Abstract] [Full Text] [Related]
[Next] [New Search]
